A novel role for NKT cells in cutaneous wound repair

Journal of Surgical Research

Volumn 168, Issue 2, 2011, Pages

  Schneider, David F ^a   Palmer, Jessica L ^a   Tulley, Julia M ^a   Speicher, John T ^a   Kovacs, Elizabeth J ^a   Gamelli, Richard L ^a   Faunce, Douglas E ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

chemokines; inflammation; NKT cells; wound healing

Indexed keywords

CHEMOKINE; COLLAGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; MACROPHAGE; MONOCYTE; MOUSE; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SKIN INJURY; WOUND CLOSURE; WOUND HEALING;

EID: 79955843177     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.09.030     Document Type: Article

References (40)

1. Joyce S. CD1d and natural T cells: How their properties jump-start the immune system. Cell Molec Life Sci 2001;58:442.
2. Kawakami K, Yamamoto N, Kinjo Y, et al. Critical role of Vα14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol 2003;33:3322.
3. Nieuwenhuis EE, Matsumoto T, Exley MA, et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nature Med 2002;8:588.
4. Faunce DE, Stein-Streilein J. NKT cell-derived RANTES recruits APCs and CD8 + T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol 2002;169:31.
5. Wilson SB, Kent SC, Patton KT, et al. Extreme Th1 bias of invariant Vα24 JαQ T cells in type 1 diabetes. Nature 1998;1998(391):177.
6. Van Kaer L. α-galactosylceramide therapy for autoimmune diseases: Prospects and obstacles. Nat Rev 2005;5:31.
7. Tahir SM, Cheng O, Shaulov A, et al. Loss of IFN-γ production by invariant NK T cells in advanced cancer. J Immunol 2001;167:4046.
8. Moodycliffe AM, Nghiem D, Clydesdale G, et al. Immune suppression and skin cancer development: Regulation by NKT cells. Nat Immunol 2000;1:521.
9. Sonoda KH, Faunce DE, Taniguchi M, et al.NKTcell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol 2001;166:42.
10. Godfrey DI, Konenberg M. Going both ways: Immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004;114:1379.
11. Faunce DE, Gamelli RL, Kovacs EJ.Arole for CD1d-NKTcells in injury-associated T cell suppression. J Leukoc Biol 2003;73:747.
12. Jameson JL, Ugarte K, Chen N, et al. A role for skin γ δ T cells in wound repair. Science 2002;296:747.
13. Baum CL, Arpey CJ. Normal cutaneous wound healing: Clinical correlation with cellular and molecular events. Dermatol Surg 2005;31:674.
14. Faunce DE, Sonoda KH, Stein-Streilein J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J Immunol 2001;166:313.
15. Kim CH, Johnston B, Butcher EC. Trafficking machinery of NKT cells: Shared and differential chemokine receptor expression among Va24 + VB11 + NKT cell subsets with distinct cytokine-producing capacity. Blood 2002;100:11.
16. Dovi JV, He L-K, DiPietro LA. Accelerated wound closure in neutrophil-delpeted mice. J Leukoc Biol 2003;73:448.
17. Wilson L, Fathke C, Isik F. Tissue dispersion and flow cytometry for the cellular analysis of wound healing. BioTechniques 2002;32:548.
18. Angel CE, George E, Brooks AE, et al. Cutting edge: CD1a+ antigen-presenting cells in human dermis respond rapidly to CCR7 ligands. J Immunol 2006;176:5730.
19. Li L, Huang L, Sung SJ, et al. NKT cell activation mediates neutrophil IFN-γ production and renal ischemia-reperfusion injury. J Immunol 2007;178:5899.
20. Woessner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1961;93:440.
21. Palmer JL, Tulley JM, Kovacs EJ, et al. Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells. J Immunol 2006;177:92.
22. DiPietro LA, Polverini PJ, Rahbe SM, et al. Modulation of JE/MCP-1 expression in dermal wound repair. Am J Pathol 1995;146:868.
23. Agaiby AD, Dyson M. Immuno-inflammatory cell dynamics during cutaneous wound healing. J Anat 1999;195:531.
24. Hwang SJ, Kim S, Park WS, et al. IL-4 secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFN-γ producing neutrophils. J Immunol 2006;177:5258.
25. Simpson DM, Ross R. The neutrophilic leukocyte in wound repair. J Clin Invest 1972;51:2009.
26. Leibovich SJ, Ross R. The role of the macrophage in wound repair. Am J Pathol 1975;78:71.
27. Singer AJ, Clark RAF. Cutaneous wound healing. N Eng J Med 1999;341:738.
28. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1983;83:4167.
29. Tomasek JT, Gabbiani G, Hinz B, et al. Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat Rev 2002;3:349.
30. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001;69:513.
31. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000;95:3032.
32. Belperio JA, Keane MP, Arenberg DA, et al. CXC chemokines in angiogenesis. J Leukoc Biol 2000;68:1.
33. Devalaraja RM, Nanney LB, Du J, et al. Delayed wound healing in CXCR2 knock out mice. J Invest Dermatol 2000;115:234.
34. Gharaee-Kermani M, Denholm EM, Phan SH. Costimulation of fibroblast collagen and transforming growth factor B1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 1996;271:17779.
35. Yamamoto T, Eckes B, Mauch C, et al. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1a loop. J Immunol 2000;164:6174.
36. Nickoloff BJ, Bonish BD, Wrone-Smith T, et al. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: Detection of T cells expressing receptors typically present on natural killer cells including CD94, CD158, CD161. Arch Dermatol 1999;135:546.
37. Nickoloff BJ, Bonish BD, Huang BB, et al. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci 2000;24:212.
38. Nickoloff BJ, Wrone-Smith T. Injection of pre-psoriatic skin with CD4 + T cells induces psoriasis. Am J Pathol 1999;155:145.
39. Sharp LL, Jameson JM, Cauvi G, et al. Dendritic epidermal T cells regulate skin homeostasis through local production of insulin-like growth factor 1. Nat Immunol 2005;6:73.
40. Jin N, Miyahara N, Roark CL, et al. Airway hyperresponsiveness through synergy of γ δ T cells and NKT cells. J Immunol 2007;179:2961.